Literature DB >> 18036423

Clinical experience with angiotensin-converting enzyme inhibitor-induced angioedema.

Nazaneen N Grant1, Ziad E Deeb, Stanley H Chia.   

Abstract

OBJECTIVES: To understand the presentation and clinical course of angiotensin-converting enzyme (ACE) inhibitor-induced angioedema and to determine management factors associated with progression to airway compromise. STUDY DESIGN AND
SETTING: Retrospective chart review of patients taking ACE inhibitors who presented to the emergency department with angioedema between December 1999 and July 2004 (n = 228). Clinical presentation, treatment, and clinical course were analyzed.
RESULTS: The oral cavity was the most common location of upper-airway angioedema. Twenty-two (10%) patients required intubation, and all were intubated within 12 hours of presentation. Of the patients who required intubation, those who were started on an H(1)-blocker were extubated earlier than those not on an H(1)-blocker (P = 0.05).
CONCLUSION: The locations of swelling and drooling on admission are predictive of the need for intubation. Other aspects of presentation, treatment, and disposition can help in management decisions for this potentially fatal condition. SIGNIFICANCE: This is the largest series to date of ACE inhibitor-related angioedema that challenges theories on the etiology and treatment of this condition.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18036423     DOI: 10.1016/j.otohns.2007.08.012

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  15 in total

1.  Angioedema after tPA: what neurointensivists should know.

Authors:  Jennifer E Fugate; Ejaaz A Kalimullah; Eelco F M Wijdicks
Journal:  Neurocrit Care       Date:  2012-06       Impact factor: 3.210

2.  A vivid example of angioedema.

Authors:  Cemil Kavalci; Mehmet Inal; Alkin Colak; Polat Durukan; Gülsüm Kavalci; Yunsur Cevik; Sibel Güldiken
Journal:  Intern Emerg Med       Date:  2009-03-14       Impact factor: 3.397

3.  When a drug does more than it needs: angio-oedema, an important adverse effect.

Authors:  Maria Betânia Ferreira; Sara M Rocha; José Miguel Maia; João Neves
Journal:  BMJ Case Rep       Date:  2014-05-23

4.  Early Acute Ischemic Stroke Management for Pharmacists.

Authors:  Michael Armahizer; Alison Blackman; Michael Plazak; Gretchen M Brophy
Journal:  Hosp Pharm       Date:  2018-08-07

5.  Guidance for diagnosis and treatment of acute angioedema in the emergency department: consensus statement by a panel of Italian experts.

Authors:  Marco Cicardi; Paolo Bellis; Giuliano Bertazzoni; Mauro Cancian; Maurizio Chiesa; Paolo Cremonesi; Pietro Marino; Nicola Montano; Claudia Morselli; Francesco Ottaviani; Roberto Perricone; Massimo Triggiani; Andrea Zanichelli
Journal:  Intern Emerg Med       Date:  2013-09-04       Impact factor: 3.397

6.  Complicated orolingual angioedema after recombinant tissue plasminogen activator treatment in stroke patients under angiotensin converting enzyme inhibitor: Report of two cases.

Authors:  Mohammad Reza Motamed; Fereshteh Nasiri; Seyed Mohammad Fereshtehnejad; Masoud Mehrpour; Babak Zamani; Bahram Haghi-Ashtiani; Farzaneh Rohani
Journal:  Iran J Neurol       Date:  2015-10-07

7.  Life threatening angioedema in a patient on ACE inhibitor (ACEI) confined to the upper airway.

Authors:  Abdulgafoor Muslim Tharayil; Arshad Hussain Chanda; Hakim Ahmad Shiekh; Mohamed Saad Elkhatib; Mohammed Nayeemuddin; Abdelhafiz Ali Ahmed Alshamandy
Journal:  Qatar Med J       Date:  2014-12-09

8.  An Unusual Case of Angiotensin-Converting-Enzyme Inhibitor-Related Penile Angioedema with Evolution to the Oropharynx.

Authors:  Jonathan G Wagner; Elias M Bench; Lee Plantmason
Journal:  West J Emerg Med       Date:  2015-11-18

9.  Phenotype standardization of angioedema in the head and neck region caused by agents acting on the angiotensin system.

Authors:  M Wadelius; S E Marshall; G Islander; L Nordang; M Karawajczyk; Q-Y Yue; I Terreehorst; E V Baranova; S Hugosson; K Sköldefors; M Pirmohamed; A-H Maitland-van der Zee; A Alfirevic; P Hallberg; C N A Palmer
Journal:  Clin Pharmacol Ther       Date:  2014-06-24       Impact factor: 6.875

10.  ACE-I Angioedema: Accurate Clinical Diagnosis May Prevent Epinephrine-Induced Harm.

Authors:  R Mason Curtis; Sarah Felder; Rozita Borici-Mazi; Ian Ball
Journal:  West J Emerg Med       Date:  2016-04-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.